Insider Transactions in Q2 2025 at Monopar Therapeutics (MNPR)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 30
2025
|
Chandler Robinson Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,865
-7.39%
|
$205,275
$35.78 P/Share
|
|
Jun 30
2025
|
Chandler Robinson Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,344
+14.4%
|
-
|
|
Jun 30
2025
|
Andrew Cittadine Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,990
-6.12%
|
$104,650
$35.78 P/Share
|
|
Jun 30
2025
|
Andrew Cittadine Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,863
+12.32%
|
-
|
|
Apr 02
2025
|
Tactic Pharma LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
33,334
-3.9%
|
$1,166,690
$35.0 P/Share
|